Article
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
14 Jun 2022
Abstract excerpt
Noninvasive disease monitoring and risk stratification by circulating tumor DNA (ctDNA) profiling has become a potential novel strategy for patient management in B-cell lymphoma. Emerging innovative therapeutic options and an unprecedented growth in our understanding of biological and molecular factors underlying lymphoma heterogeneity have fundamentally increased the need for precision-based tools facilitating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
